Erythrocyte Sedimentation Rate (ESR) is a commonly used clinical blood test primarily used to detect the sedimentation rate of red blood cells under specific conditions. Although ESR is not specific to any particular disease, it holds significant value in assessing disease activity, monitoring therapeutic effects, and aiding in the differential diagnosis of certain conditions. ESR Vials, also known as sodium citrate 4:1 tubes, are commonly used sampling tubes for ESR testing. This article will introduce the key points of ESR testing and its clinical significance in detail.
ESR Vials, or sodium citrate 4:1 tubes, contain a specific ratio of sodium citrate to prevent blood coagulation. The ratio of blood to the additive in the tube is 4:1, with sodium citrate concentrations of 0.109M (3.2%) or 0.129M (3.8%). This specific ratio ensures normal sedimentation of red blood cells within the tube, making ESR test results more accurate.
For ESR testing, it is crucial to use samples collected in ESR Vials. To avoid affecting the test results, patients are usually required to fast for 8 hours to keep the substance concentration in their blood stable. After collecting the sample, the sedimentation rate of red blood cells is measured, providing doctors with information about the patient's inflammation, infection, or other pathological states.
ESR testing using ESR Vials has clinical importance in various situations. Firstly, monitoring disease progression is a key use of ESR testing. Accelerated ESR often indicates relapse or worsening of tuberculosis and rheumatic diseases. When the condition improves, ESR gradually returns to normal levels. Therefore, ESR can be used for disease monitoring and to assist in evaluating therapeutic effects.
Additionally, ESR testing is frequently used for differential diagnosis. For example, in differentiating myocardial infarction from angina, the former is usually associated with accelerated ESR, while the latter may show no significant change. Similar scenarios include distinguishing between gastric cancer and gastric ulcer, or malignant tumors and benign cysts. Since patients with malignant tumors usually have a faster ESR, this indicator provides valuable diagnostic information for doctors.
Moreover, ESR Vials are effective in detecting abnormal proteins in plasma, especially in patients with multiple myeloma. The presence of a large number of abnormal globulins significantly accelerates ESR, making ESR a vital tool in diagnosing and monitoring this disease.
ESR test results obtained with ESR Vials can be roughly categorized as normal, accelerated, or slowed down based on reference ranges. Generally, the normal ESR range for men is 0-15 mm/h, and for women it is 0-20 mm/h. If the results show accelerated ESR, it could indicate the following conditions:
Physiological Increase
For example, ESR often accelerates due to increased fibrinogen levels during menstruation, pregnancy, and in the elderly.
Pathological Increase
Acute or chronic inflammation, malignant tumors, anemia, and hypercholesterolemia can all cause accelerated ESR. For instance, ESR significantly speeds up in patients with severe anemia, especially when hemoglobin levels drop below 90 g/L, making this trend even more noticeable.
On the other hand, slowed ESR often has less clinical significance and may be related to an increased number of red blood cells or significantly decreased fibrinogen levels. For instance, in conditions like dehydration-induced hemoconcentration or polycythemia vera, ESR slows down.